Yüklüyor......

DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis

Sitagliptin is a dipeptidyl peptidase-4 inhibitor commonly used in the treatment of type 2 diabetes mellitus for glycaemic control. Concerns have arisen regarding adverse events caused by this drug, particularly concerning arthralgias. Here, we report on a 56-year-old man being treated with sitaglip...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Case Rep
Asıl Yazarlar: Padron, Simonette, Rogers, Everett, Demory Beckler, Michelle, Kesselman, Marc
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720914/
https://ncbi.nlm.nih.gov/pubmed/31444259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228981
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!